No Data
Ginwa Enterprise(Group) Inc. (600080.SH): Using no more than 0.1 billion yuan of idle raised funds to temporarily supplement working capital.
gelonhui Dec. 5th | ginwa enterprise(group) inc. (600080.SH) announced that on December 4, 2024, the company held the thirteenth meeting of the tenth board of directors, the ninth meeting of the tenth supervisory board, and approved the "Proposal on Using Part of the Unused Raised Funds to Temporarily Supplement Working Capital", agreeing that the company will temporarily supplement working capital using no more than RMB 0.1 billion of unused raised funds, with a period of use not exceeding 12 months from the date of approval by the company's board of directors.
Retail Investors Invested in Ginwa Enterprise (Group) Inc. (SHSE:600080) up 16% Last Week, Insiders Too Were Rewarded
Ginwa Enterprise(Group) Inc. (600080.SH): Controlling shareholder and some concerted actions have terminated their concerted action relationship.
On November 20th, Gelonghui reported that ginwa enterprise(group) inc. (600080.SH) announced that it recently received a "Notice Letter" and "Agreement to Terminate the Relationship of Joint Action" from the controlling shareholder, actual controller Xing Boyue, and its concerted persons Du Ling, Yang Bei, and Zhong Chunhua. On November 18, 2024, Zhong Chunhua signed the "Agreement to Terminate the Relationship of Joint Action" with Xing Boyue, Du Ling, and Yang Bei, effective from November 19, 2024, thereby terminating the relationship of concerted action with Xing Boyue and the other concerted persons Du Ling and Yang Bei, and they will no longer constitute concerted action. After the termination of the concerted action relationship, Xing Boyue, Du Ling, and Yang Bei will continue to act according to the "
Ginwa Enterprise (Group) Inc. (600080.SH): Huasen medical will further build complete product lines such as artificial knee joints and hip joints.
Ginwa Enterprise(Group) Inc. (600080.SH) stated on the investor interaction platform on November 7 that the new factory area of Huasen Medical Instruments Co., Ltd. located in Wujin High-tech Zone, Changzhou is expected to be officially put into use by the end of the year. Currently, the company is engaged in the research and development, production, and sales of artificial joint products. Huasen Medical will further build complete product lines such as artificial knee joints, hip joints, and more. Currently, it has obtained registration certificates for imported knee joints and domestic knee joints, and has entered the national secondary joint procurement, starting to sell in the market.
Jinhua Enterprise (Group) Co., Ltd. Report for the Third Quarter of 2024
ginwa enterprise(group) inc. (600080.SH): net income of 30.77 million yuan in the first three quarters, a year-on-year increase of 807.59%.
Gelonghui on October 29th: Ginwa Enterprise(Group) Inc. (600080.SH) released its third-quarter report. The revenue for the first three quarters was 0.419 billion yuan, a year-on-year increase of 4.00%. The net income was 30.77 million yuan, a year-on-year increase of 807.59%. The non-net profit was 17.3687 million yuan, a year-on-year decrease of 13.23%, with basic earnings per share of 0.0840 yuan.
Some Confidence Is Lacking In Ginwa Enterprise (Group) Inc. (SHSE:600080) As Shares Slide 29%
No Data
